Cerapedics receives OK in Europe and Australia to use its i-FACTOR Flex FR biologic bone graft
WESTMINSTER - Cerapedics , a privately held orthobiologics company, announced it has received the CE Mark in Europe and Therapeutic Goods Administration (TGA) listing in Australia for its new... Read More
Thursday January 15, 2015
Cerapedics: First i-FACTOR bone graft clinical study shows significant favorable outcomes
WESTMINSTER - Cerapedics announced results from the first prospective clinical study evaluating the safety and efficacy of its i-FACTOR bone graft in anterior lumbar interbody fusion (ALIF)... Read More
Tuesday October 21, 2014
Cerapedics closes on $9M loan from GE Capital
WESTMINSTER - Cerapedics , an orthobiologics company focused on developing and commercializing its proprietary synthetic peptide technology program, announced it has closed on a $9 million venture... Read More
Tuesday April 15, 2014
Cerapedics treats 10,000th patient with i-FACTOR bone graft
WESTMINSTER - Cerapedics Inc ., a medical device company pioneering the use of peptide-enhanced bone grafting materials in spine, trauma and orthopedic surgery, announced it has treated more... Read More
Monday March 4, 2013
Cerapedics secures $19M in equity financing to advance bone graft R&D
WESTMINSTER - Cerapedics Inc. today announced it has completed a Series C round of private equity financing totaling $19 million. The new round was led by new investors Medimmune Ventures... Read More
Wednesday December 12, 2012
IN Sponsors
Browse
Entrepreneurial by Nature
